Nonbacterial Thrombotic Endocarditis in Pancreatic Cancer Endocardite trombotica non batterica in associazione con una neoplasia pancreatica

Nonbacterial Thrombotic Endocarditis in Pancreatic Cancer. B. Piovanelli, R. Rovetta, I. Bonadei, E. Vizzardi, A. D'Aloia, M. Metra. Nonbacterial thrombotic endocarditis (NBTE), known as marantic endocarditis, is a phenomenon due to hyperco- agulability with a complex pathogenesis. Originally de- scribed by Ziegler, the lesions of NBTE were considered to be fibrin thrombi deposited on normal or superficially de- generated cardiac valves (1). Numerous reports have identi- fied the relationship between NBTE and a variety of differ- ent inflammatory states, including chronic diseases like ma- lignancy and autoimmune disease (2, 3). NBTE is a serious manifestation of prothtombotic state that is characterized by the deposition of thrombi on previously undamaged heart valves in the absence of a bloodstream bacterial infection and by the increased frequency of arterial embolic events in pa- tients with chronic debilitating diseases. Although hyperco- agulability is often seen in patients with pancreatic cancer, NBTE has rarely been reported antemortem. We report a case of marantic endocarditis in patient with pancreatic can- cer, in which neurological symptoms preceded the diagnosis of pancreatic cancer.

[1]  Á. Robles-Marhuenda,et al.  Non-bacterial Thrombotic Endocarditis , 2019 .

[2]  A. Duncan,et al.  Psychosis due to non-bacterial thrombotic endocarditis. , 2010, Age and ageing.

[3]  M. Streiff,et al.  Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. , 2007, The oncologist.

[4]  J. Kizer,et al.  Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. , 2006, The American journal of cardiology.

[5]  M. Levine,et al.  Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer☆ , 2003 .

[6]  R. Bick Cancer-associated thrombosis. , 2003, The New England journal of medicine.

[7]  M. Prins,et al.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.

[8]  M. Prins,et al.  Venous thromboembolism and occult malignancy. , 2001, Thrombosis research.

[9]  M. Nakagawa,et al.  Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin. , 1993, Thrombosis research.

[10]  M. Hughson,et al.  Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  E. Cho,et al.  Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. , 1987, The American journal of medicine.

[12]  W. Bell,et al.  Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. , 1985, The American journal of medicine.

[13]  T. Reagan,et al.  The thrombotic syndrome associated with carcinoma. A clinical and neuropathologic study. , 1974, Archives of neurology.

[14]  V. Ferrans,et al.  Cardiovascular lesions in collagen-vascular diseases , 2005, Heart and Vessels.

[15]  M. Fishbein,et al.  Nonbacterial thrombotic endocarditis: a review. , 1987, American heart journal.

[16]  J. Levin,et al.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. , 1977, Medicine.

[17]  D. Armstrong,et al.  Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases. , 1973, The American journal of medicine.

[18]  A. Trousseau Clinique médicale de l'Hôtel-Dieu de Paris , 1877 .